It has been reported that ILEI plays a critical role in promoting EMT and metastasis in various cancers, including breast cancer 27, gastric cancer 28, melanoma 29, colorectal cancer 30, and liver cancer 31, either independently or in combination with TGF-β. Here, TGFB1 is linked to breast carcinoma.